India's vaccine distribution challenge, explained in five charts
The cold chain infrastructure in the country is skewed towards richer, urbanized centres. Roughly 4 cold chain points serve 100,000 population in Gujarat, whereas there is just one cold chain point for the same number of people in Jharkhand.
When the covid-19 pandemic began spreading, India, like most other countries, was left scrambling for protective gear and medical equipment to manage the crisis. As the world prepares itself for the launch of vaccines that are expected to bring the pandemic to an end, India may be better prepared at least on one count. As the world’s leading vaccine manufacturer, India may have better access to vaccines than many other parts of the developing world. Serum Institute of India (SII) alone is a producer of more than 1.5 billion vaccine doses every year and is expected to produce 1 billion doses of the Novavax vaccine by 2021.